
ä»å¬ã®ãããªãã«ãããã¯ããèŠåããäž»èŠã¡ãã£ã¢ - ãã®èæ¯ã«ã¯äœãããã®ãïŒ
å èšäºã¯ãã¡ã/Original article here
ã€ã³ãã«ãšã³ã¶ãRSVãCOVID-19ã¯ãç¹å®ã®é«ãªã¹ã¯ã®äººã ã«ãšã£ãŠã¯åé¡ã§ããå±éºã§ããããããã«é¢é£ããå šäœçãªãªã¹ã¯ã¯ãã»ãšãã©ã®äººã«ãšã£ãŠç¡èŠã§ãããã®ã§ãã
ã¹ããŒãªãŒèŠçŽ
äž»èŠã¡ãã£ã¢ã«ãããšãåŒåžåšææçã«ããå ¥é¢ãå¢å ããCOVID-19ãå£ç¯æ§ã€ã³ãã«ãšã³ã¶ãåŒåžåšåèäœãŠã€ã«ã¹ïŒRSVïŒãæµéããŠããããšããããå°éå®¶ãã¯ãã®å¬ã«ãäžå€§æµè¡ãã®å¯èœæ§ããããšèŠåããŠããŸãã
ç±³åœçŸç 察çäºé²ã»ã³ã¿ãŒïŒCDCïŒã®å ±åã«ãããšãCOVID-19ã確èªãããæ£è ã®æ°èŠå ¥é¢ã1ïŒ å¢å ãããšã®ããšã§ããCOVID-19ã®ãžã£ããžã£ãçãå šç±³ã§æãé«ãã¡ã€ã³å·ã§ã¯ãCOVID-19ã®å ¥é¢ãæãå€ããªã£ãŠããŸããRSVã®çäŸãå£ç¯å€ãã®é«ãã§ãã
éå»3幎éã«éãããããã¹ãŠã®èšŒæ ãããã§ã€ã¹ãã¹ã¯ã§ã¯ãŠã€ã«ã¹ææã𿡿£ãé²ããªãããšãè£ä»ããŠããã«ããããããããå¥åº·ã®å°éå®¶ãã¯ä»ãŸãèªäž»çãªå®€å ãã¹ã¯ãåŒã³ãããŠããã
çŸåšãåŠå©Šãæ°çå ãé«éœ¢è ã察象ãšããåã®RSVã¯ã¯ãã³ãæºåãããŠããããã®ãã¡ã®ããã€ãã¯ãmRNAã®æè¡ãããŒã¹ã«ããŠããŸãã
RSVã®ã¯ã¯ãã³ã¯ãæäœäŸåæ§å¢åŒ·ïŒADEïŒãšåŒã°ããçŸè±¡ã§ãç ç¶ãæªåãããåŸåãæ ¹åŒ·ãããããŸã§éçºã«æåãããã®ã¯ãªãã£ãã
äž»èŠã¡ãã£ã¢ã«ãããšãåŒåžåšææçã«ããå ¥é¢ãå¢å ããŠããããå°éå®¶ãã¯ã人ã ãCOVID-19ãå£ç¯æ§ã€ã³ãã«ãšã³ã¶ãåŒåžåšåèäœãŠã€ã«ã¹ïŒRSVïŒã«ææãããã®å¬ãäžå€§æµè¡ãã®å¯èœæ§ããããšèŠåããŠããŸãã
ãCDCïŒç±³åœçŸç 管çäºé²ã»ã³ã¿ãŒïŒã¯ãç±³åœã§COVID-19ã確èªãããæ£è ã®æ°èŠå ¥é¢ã1ïŒ å¢å ãããšå ±åããŠãã ããšã10ææ«ã«YahooïŒNewsãå ±ããŸããã
ããããã¯ã¯ãã³æªæ¥çš®è ã®ãã³ãããã¯ãšã¯ã»ã©é ããçŸåšãCOVID-19æ£è ã®ã»ãšãã©ã¯ãå®éãå®å šã«ãžã£ããžã£ãæ¥çš®ãããŠãããYahoo!ãã¥ãŒã¹ãææããããã«ïŒããŒã¹ã¿ãŒãææ°ã®ç¶æ ã«ä¿ã€ããçã«ä¿ãåã«ïŒã
ãCOVIDã«ããå ¥é¢ãæãå€ãå·ã¯ã¡ã€ã³å·ã§ãããã®å·ã¯ãå®å šãªã¯ã¯ãã³æ¥çš®çãå šç±³ã§æãé«ãå·ã®äžã€ã§ãããããã¯ãäžæ¬¡æ¥çš®ã®ã·ãªãŒãºïŒããã1åã2åã§ãããã¯åããŸããïŒãåããæåŸã®æ¥çš®ãã2é±éãçµéãã人ãæå³ããŸãããšè¿°ã¹ãŠããŸãã
RSVã®çäŸãå£ç¯å€ãã®é«ãã§ãããã«ãã¢ã¢ã®ãžã§ã³ãºã»ãããã³ã¹å°å ã»ã³ã¿ãŒã®å ±åãã£ã¬ã¯ã¿ãŒã§ããããŒã¬ã¬ããã»Rã»ã ãŒã³å士ã«ãããšãåç é¢ã¯ ãRSVã®æ£è æ°ã®å¢å ããã®ä»ã®çç±ã§æ£è ãæ¥å¢ããŠãããåšèŸºã®å€ãã®ç é¢ãåãããã«çŽé¢ããŠãã ããšã®ããšã§ãã
RSVã¯ã¯ãã³ã売ã蟌ãããã®è ãæå¥
ææã¯äººã売ããšããããã¯ã¯ãã³ã«é¢ããŠèšãã°ã倧æè£œè¬äŒç€Ÿãäœ¿ãæ Œèšã§ããããšã¯ééããªãããã®å žåçãªäŸããæè¿Voxã«æ²èŒãããèšäºã§ãããæ°ããRSVã¯ã¯ãã³ãç»å ŽãããThis Is Very, Very Good News ããšããèŠåºãã§ããã
ãªãè¯ããã¥ãŒã¹ãªã®ãïŒãªããªããRSVã¯çŸåšç é¢ã§èŠããããéšä¹±ã®å€ããåŒãèµ·ããæªåœ¹ãã ããã§ãããVoxã¯å€å žçãªææãã«ããåºçããŠããã
ãRSVã¯äžè¬çã«é¢šéªã®çç¶ãåŒãèµ·ãããŸãããéåžžã«è¥ã人ãé«éœ¢è ã§ã¯é床ã®èºçãææçãåŒãèµ·ããå¯èœæ§ããããŸãããããŠã颚éªã®å£ç¯ãå¢ãããã¹ã¿ãŒããããŸãããã
ã10æ22æ¥æç¹ã§ã1æ³æªæºã®èµ€ã¡ããã¯2019幎ã®åãæç¹ã®6åã®å²åã§å ¥é¢ããŠãããå šå¹Žéœ¢ã®å ¥é¢çã7åãšãªã£ãŠããŸããã
ãæ¯å¹ŽãäœçŸäººãã®åã©ããRSVã§æ»äº¡ããäœäžäººãã®åã©ããå ¥é¢ããŠãã...RSVçŸæ£ã¯ãè¥ãå°å ç§å»ãæããããšãåŠã¶æåã®å°å çŸæ£ã®1ã€ã ãšãïŒã¯ãªãŒãã©ã³ãã®å°å ææçå°éå»ïŒããšã€ããŒã»ãšãã¯ãŒãºã¯è¿°ã¹ãŠããã
ããã®ææçã«ããã£ãèµ€ã¡ããã¯ãã²ã©ãå³ãããè «ããæ°éãéããŠç©ºæ°ãåããã®ã«èŠåŽããã®ã§ãå鳎ã®ãããªé³ãåºããäžåºŠèŠããå¿ããããªããããªãã®ã§ãããšåœŒå¥³ã¯èšã£ãïŒ
ãç±³åœã§ã¯ããã®ææçã«ãããæ¯å¹ŽçŽ58,000人ãå ¥é¢ãã100ïœ300äººãæ»äº¡ããŠãããä¹³å ã®å ¥é¢åå ãšããŠã¯å šç±³äžäœãšãªã£ãŠããŸããã
ãæ©ç£ã§çãŸããèµ€ã¡ãããèºã®ç æ°ãå¿èã«ç°åžžã®ããèµ€ã¡ããã«ã¯ç¹ã«å±éºãªææçã§ãããé廿°å幎éã«RSVã§æ»äº¡ããã¢ã¡ãªã«ã®å¹Œå ã®çŽ40ïŒ ã¯ããã以å€ã¯å¥åº·ãªåäŸã§ãããã
ãRSVãç±³åœã§ããã«æ·±å»ã§ããããšãäžççã«ã¯ãã£ãšæ·±å»ã§ããæ¯å¹Žãäžçäžã§12äžäººã®ä¹³å ãRSVã«ãã£ãŠæ»äº¡ããŠãããšæšå®ãããŠããŸã...çŸåšã倧人ãåäŸãRSVã«å¯ŸããæãŠã€ã«ã¹æ²»çã¯æ¿èªãããŠããŸããããçŸåšããäžã€ã®äºé²æ³ãå®ç§ãšã¯èšããŸãã...ã
ãèµ€ã¡ããã«ã¯ãã£ãšè¯ããã®ãå¿ èŠã§ããæããªã¹ã¯ã®é«ãä¹³å ã ãã§ãªãããã¹ãŠã®ä¹³å ããã®å£ç¯ã®çœãããå®ãããšãã§ããæé ãªãã®ãå¿ èŠã§ãã倧人ãã確å®ã«èšå€§ãªéã®ç æ°ãåŒãèµ·ãããŠã€ã«ã¹ãã身ãå®ããã®ãå¿ èŠã§ããçæ³çã«ã¯ãã€ã³ãã«ãšã³ã¶ã®äºé²æ¥çš®ãšåããããã以äžã®ãã®ãå¿ èŠã§ããããšè¿°ã¹ãŠããŸãã
ãã€ã³ãã«ãšã³ã¶ã®äºé²æ¥çš®ãšåããããè¯ããã®" ãšããã®ã¯æ¬åœã§ããïŒã
2017/2018幎ã®å£ç¯æ§ã€ã³ãã«ãšã³ã¶ã¯ã¯ãã³ã®ç±³åœã«ãããèª¿æŽæžã¿ç·å广ã¯ãAåã€ã³ãã«ãšã³ã¶ããã³Båã€ã³ãã«ãšã³ã¶ãŠã€ã«ã¹ææã«å¯ŸããŠããã36ïŒ ã§ããã2005幎ãã2015幎ã«ãããŠãã€ã³ãã«ãšã³ã¶ã¯ã¯ãã³ã®èª¿æŽæžã¿ç·å广ã¯åå以äžã®æéã§50ïŒ æªæºã§ããã2004-05幎ã®ã·ãŒãºã³ã«ã¯ããã10ïŒ ã®äœãã§ãã£ãã
COVID-19ãžã£ã以å€ã«ãåžè²©ã®è£œåãåå以äžã®ç¢ºçã§å¹æãçºæ®ããªãã«ãããããããæšå¥šããã矩ååãããŠãããšããäŸãèŠã€ããã®ã¯å°é£ã§ãã
ããããVoxã«ããã°ããRSVã¯ã¯ãã³ã¯è¶ 广çããªã®ã§ãå¿é ã¯ãããªãã
ãããªããšãã©ããã§èããããšããããããªïŒ
éåžžèãªCOVID察çãåéãããããšãæåŸ ãã
äºæ³éããéå»3幎éã«éãããããã¹ãŠã®èšŒæ ãã2020幎ã«ãã§ã«åãã£ãŠããããšãã€ãŸããã§ã€ã¹ãã¹ã¯ã¯ãŠã€ã«ã¹ææãæ¢ããã®ã«äœã®åœ¹ã«ãç«ããªãããšãè£ä»ããŠããã«ããããããããå¥åº·å°éå®¶ããã¡ã¯åã³å±å ãã¹ã¯ã®èªäž»èŠå¶ãæ±ãå§ããŠããã®ã§ããã
ãããŠããããŸã§ãšåæ§ã«ãå®éã®ç§åŠçãªèšŒæ ããªãäžã§ã代ããã«çŸåŸ³ã«çŠç¹ãåœãŠãç©èªãå±éãããŠããŸãã
ãã¹ã¯ã¯ãã¹ãŠã®äººãå®ããã®ã§ããããèªåã®åœ¹å²ãæãããããã«ççšããã®ã ãšèšãããŠããŸãã
ã¯ã¯ãã³æ¥çš®ãåãã§ããã€ã³ãã«ãšã³ã¶ã¯ã¯ãã³ãã³ãã19ã®äºé²æ¥çš®ã广ããªãããšã蚌æãããŠããã®ã«ãæ¥çš®ã®æšå¥šã¯ç¶ããŠããŸãã
ãããŠä»ã·ãŒãºã³ã¯ãäž¡æ¹åããããšãæ±ããããŠããã®ã§ã
2023幎ã«åã®RSVã¯ã¯ãã³ãèªçããèŠèŸŒã¿
RSVãæ·±å»ãªãªã¹ã¯ãšããŠã¯ããŒãºã¢ãããããããã«ãªã£ãã®ã¯ãå²äžåã®RSVã¯ã¯ãã³ãæºåãããŠããäºå®ãèæ ®ããã°çè§£ã§ããã ãããCNNã«ãããšã4çš®é¡ã®RSV泚å°ããç±³åœé£åå»è¬åå±ïŒFDAïŒã®å¯©æ»ã«è¿ã¥ããŠãããã»ãã10çš®é¡ä»¥äžãè©Šéšæ®µéã«ãããšããã
ãã®äžã«ã¯ãèµ€ã¡ããå°çšã®ãé·æéäœçšå泚å°ããå«ãŸããŠããããçåŸãããæäžããããšã§ãã6ã«æãã®éãRSVããå®ãããšãã§ããã
ããããããã¡ãã£ã¢ãçšèªã®åºæ¬çãªæå³ã®èªèãå€ããããšããå®ç§ãªäŸã§ãªããšããã°ãç§ã¯äœããããªã®ãåãããªãã6ã¶æãšããã®ã¯é·æéäœçšåã§ã¯ãããŸããã
æŽå²çã«ãã»ãšãã©ã®ã¯ã¯ãã³ã¯ãå°ãªããšãæ°ã¶æã§ã¯ãªãæ°å¹Žéãæäœã®ã¿ã®ãä¿è·ããæäŸããŠããŸããããã¹ãŠã®ã¯ã¯ãã³ã¯ãäœæ¶²æ§æäœã«ããä¿è·ãããã¯ããã«éèŠãªçŽ°èæ§å ç«ã«ããä¿è·ã«å€±æããŠããããšãèªèããŠãã ããã
ãããããã®æ¥µããŠçãæäœä¿è·æéã¯ãmRNAæè¡ã®ç¹åŸŽã§ãããå®éãå°ãªããšããããã®æ°ããRSVã¯ã¯ãã³ã®ããã€ãã¯mRNAãããŒã¹ã«ããŠããŸãã
ã¢ããã¯ã2023幎ã«çºå£²äºå®ã®RSVã®mRNA泚å°è¬ãéçºäžã§ãããšçºè¡šããã
ãŸããCOVID-19ãRSVãã€ã³ãã«ãšã³ã¶ãçµã¿åãããmRNA泚å°è¬ã«ãåãçµãã§ããïŒæçµçã«ã¯ãæ¯å¹Žå ¥é¢ãåŒãèµ·ããäžäœ10çš®ã®ãŠã€ã«ã¹ããã¹ãŠã«ããŒããmRNA泚å°ãäœããããšããŠããïŒã
ã€ã³ã»ã³ã¯ãŸããCOVID-19泚å°ã«äœ¿ãããã®ãšåãæè¡ã§ããã¢ãããŠã€ã«ã¹ãã¯ã¿ãŒã䜿ã£ãRSV泚å°ã«åãçµãã§ããããã¡ã€ã¶ãŒãšã°ã©ã¯ãœã»ã¹ãã¹ã¯ã©ã€ã³ïŒGSKïŒã¯åŠå©Šãšé«éœ¢è åãã®ãã¿ã³ãã¯è³ªãµããŠããããRSVã¯ã¯ãã³ã詊éšäžã ã
ãã©ãŒãã¹èªã«ãããšããã¡ã€ã¶ãŒç€Ÿã¯11æ1æ¥ãRSVã¯ã¯ãã³ã®FDAèªå¯ãæ±ããæºåãæŽã£ãããšãçºè¡šããã
èšåºè©Šéšã§ã¯ããã®æ³šå°ã¯åŠåš äžã®æ¯èŠªã«æäžããããã®å¹æã¯RSVãäºé²ã§ãããã©ããã§ã¯ãªããçåŸæ°ã«æã®å ¥é¢äžã®èµ€ã¡ããã®ææçã®éç床ã«ãã£ãŠæž¬å®ãããããã§ãã
RSVã¯ã¯ãã³ãåžå Žã«åºãªãã£ãçç±
RSVã®ã¯ã¯ãã³ã¯ããããŸã§éçºã«æåãããã®ã¯ãªãããªããïŒ
ãªããªããã¯ã¯ãã³ã«ã¯ãæäœäŸåæ§å¢åŒ·ïŒADEïŒãšåŒã°ããçŸè±¡ã§ãç æ°ãæªåãããåŸåãæç¶ããŠããããã§ããã
CNNã®èª¬æã¯ä»¥äžã®éãã
ãRSVãã身ãå®ã广çãªæ¹æ³ã®æ¢æ±ã¯ã1960幎代ã«è¡ãããæ²æšãªã¯ã¯ãã³è©Šéšã§2人ã®åäŸãæ»äº¡ããåŸãæ°å幎éåæ»ããŠãããã
ããã®ç ç©¶ã§ã¯ãRSVãŠã€ã«ã¹ãååŠçã«äžæŽ»æ§åãããã§ãŠãã³ãšåŒã°ããæåãæ··ããŠäœã£ãã¯ã¯ãã³ããã¹ãããŸããããã®ã¯ã¯ãã³ã¯ã1966幎ãã1968幎ã«ãããŠãã¢ã¡ãªã«ã®èšåºè©ŠéšäŒå Žã§ãã¹ãããããã
ãåœåã¯ããã¹ãŠãããŸããã£ãŠããããã«èŠããããã®ã¯ã¯ãã³ã¯åç©ã§ãã¹ããããããèããæ¬¡ã«åäŸãã¡ã«æäžããã圌ãããŸãããåå¿ããããã«èŠãããã
ãã¢ã€ãªã¯å€§åŠã®åŸ®çç©åŠãšå ç«åŠã®ææã§ããã¹ãã£ãŒãã³ã»ãŽã¡ã«ã¬ã¯ã20幎以äžRSVãç ç©¶ããŠããããã®ãŠã€ã«ã¹ã«å¯Ÿããããç²åã¯ã¯ãã³ãéçºããŠãã人ç©ã§ãããã
ããã®è©Šéšã«ã€ããŠçºè¡šãããç ç©¶ã«ãããšãåŸã«RSVã«ããã£ãã¯ã¯ãã³æ¥çš®å ã®80ïŒ ãå ¥é¢ãå¿ èŠãšããã®ã«å¯Ÿãããã©ã»ãæ¥çš®å ã¯ããã5ïŒ ã§ãã£ãããã§ãããã®è©Šéšã«åå ããä¹³å ã®ãã¡2äººãæ»äº¡ãããã
ããã®èšåºè©Šéšã®çµæã¯ãã¯ã¯ãã³ç§åŠã«å€§ããªè¡æãäžãããRSVã«å¯Ÿããæ°ããã¯ã¯ãã³ãšæ²»çæ³ãéçºããåªåã¯ãç ç©¶è ãäœããããªã«ããŸããããªãã£ãã®ããè§£æããããšããã«ã€ããŠåæ¢ããã»ã»ã»ãå®éãå€ãã®ç¹ã§ãæã ã仿¥ã¯ã¯ãã³ã®å®å šæ§ãç£èŠããããã«æã£ãŠããããã€ãã®ãã®ã®çç±ã§ããããšãŽã¡ã«ã¬ã¯èšã£ããã
ã¯ã¯ãã³ã®å®å šæ§ãç£èŠããŠãã人ã¯ããã®ãïŒ
æ²ããç®èãªããšã«ãç§ãã¡ã¯ã¯ã¯ãã³å®å šæ§ç£èŠããŒã«ãå°å ¥ããŠããŸããããã®ããŒã¿ã¯é©åã«è©äŸ¡ããããæææ±ºå®ããã»ã¹ã§äœ¿çšãããŠããŸããã
ã€ãŸããç±³åœã§ã¯ã¯ã¯ãã³å®å šæ§ç£èŠãæ©èœããŠããªãã®ã§ãã
ããFDAãšCDCãå®éã«å®å šæ§ãç£èŠããæå³ãããšããã«èªç±ã«äœ¿ããããŒã«ã䜿ã£ãŠãããªãã°ãã³ãã19ã®æ³šå°ã¯çºå£²åŸæ°ã«æã§äžæ¢ãããŠããã§ãããã
ã©ãèããŠããæŽå²äžæãå±éºã§èŽæ»çãªæ³šå°ãªã®ã ãããããFDAãšCDCã¯å®å šæ§ã«é¢ããã·ã°ãã«ããã¹ãŠç¡èŠããæè¿ã«ãªã£ãŠCOVID-19泚å°ãå°å çšã¯ã¯ãã³æ¥çš®ã¹ã±ãžã¥ãŒã«ã«è¿œå ããã
ããã³ãã19ã®å®å šæ§ç£èŠããªãã®ãªããä»ã®ã©ããªæ°ããã¯ã¯ãã³ãmRNA泚å°ã«ãå®å šæ§ç£èŠãæåŸ ããçç±ã¯ãªãã ããã
ããã«ãç ç©¶è ãADEãå ç«å·ã蟌ã¿ãèµ·ãããªãRSVã¯ã¯ãã³ãäœãæ¹æ³ãå®éã«çºèŠãããšä»®å®ããçç±ããªãããã®2ã€ã¯ããå ç«ããããç åäœã«ãã®åŸããããããšãã«å ç«åå¿ãå€è³ªãããå®éã«ã¯ã¯ãã³ãæããªãã£ãå Žåãããç æ°ã«ãªãããããªãã
ããããCOVID-19ãæ¥çš®ãã人ã ã«ADEãšå ç«å·ã蟌ã¿ããããã¯æåæ§å眪ã®å åãçŸããŠããããšãèãããšããã®ãããªããšãæ³å®ããåäŸã¯ãªãã®ã§ããã
COVID-19ã®ãã³ãããã¯ã¯ãå»çä»å ¥ã®ããã®èªå¯ãšæ¿èªã®ããã»ã¹ãæ ¹æ¬çã«å€ããŠããŸã£ãããšãèªèããããšãéèŠã§ãããã¹ãŠãæ¥ãããã§é²ããããããã«ãªããçæéã§å©çãåŸãããã®éæžãéãããã
10幎以äžã«ããã詊éšãå¿ èŠãšãã代ããã«ãmRNA泚å°ã¯ãããæ°ã«æã®è©Šéšã§å±éããããã®å®å šæ§ã®å€ãã¯COVID-19泚å°ã®å®å šæ§ãšããããã®ã«åºã¥ããŠããã
ãCOVID-19泚å°åŸã®æå®³äºè±¡å ±åã¯ãã¯ã¯ãã³æå®³äºè±¡å ±åã·ã¹ãã ïŒVAERSïŒã«140äžä»¶ä»¥äžèšé²ãããŠããããã®äžã«ã¯31,600人ãè¶ ããæ»äº¡äŸãå«ãŸããŠããããã ãã
FDAãšCDCã«ããã°ããããã®æ»äº¡äŸã®ã©ãããã¯ã¯ãã³æ¥çš®ã«èµ·å ãããã®ã§ã¯ãªããçµ±èšçã«äžå¯èœãªããšã§ããã
ææãç œãã®ã¯æåŸãè²ãŠãããã®éå ·
ãã€ãªã»ãã¥ãªãã£ãŒã®å±æ©ã¯ãã€ãŸã§ãç¶ãå¿ èŠãããããªããªããããããã°ã¬ãŒãã»ãªã»ãããã®èåŸã«ããäž»èŠãªæ£åœåçç±ã ããã ãã ããããããã®3幎éããå ¬å ±ã®å®å šãã®ãŽãŒã«ãã¹ããã©ãã©ãé ãããäžæ¹ã ã£ãã®ã ã
ãããŠãäžå®æéããšã«ã空ã¯ãŸã èœã¡ãŠããããæ²¹æã¯çŠç©ããšããããã³ã»ãªãã«ã®èŠåãç¹°ãè¿ãããã
ç§ããå¬ã«ãããŠããã¹ã¯ãããŠäºé²æ¥çš®ãåããªã人ã«ã¯ããŸãç Žæ» çãªããšãèµ·ããã ãããããæ®µéã§ã屿ããŠåŸãã°åŸãã»ã©ã屿ããŠåŸããªããã°ãªããªãããšã«æ°ä»ããªããã°ãªããªãã
圌ããããªããã奪ããã®ã«ã¯æ¬åœã«çµããããªããããªãã®æ¿åºã¯æ±ºããŠïŒ»ç©ºçœãåããªããšãã信念ã«ããã¿ã€ãããšã¯ãæ¥ã«æ¥ã«å±éºã«ãªãã€ã€ããã®ã§ãã
ãŸããæ¿åºãç©¶æ¥µã®æš©åè ã§ãªãããšãèªèããããšãéèŠã§ããæ¿åºã®åœ¹äººãããã°ãã°ãã£ãŒãã»ã¹ããŒããšåŒã°ãããã®ããåœä»€ãåããŠããã
æ¿åºã§ã¯ãªãã誰ã«ã責任ãè² ãããæ°ããäžçç§©åºãå®çŸããããã«ãã¹ãŠã®äººã«åœ±é¿ãäžããæãäžççãªé ããæš©åæ©æ§ã§ãã
é廿°å¹Žéããã®åœ±ã®æš©åè éå£ã¯ãæ°äžçç§©åºïŒNWOïŒãšããèšèã§åŒã°ããŠããã
2020幎ãäžççµæžãã©ãŒã©ã ã衚èå°ã«ç«ã¡ããã°ã¬ãŒãã»ãªã»ããããçºè¡šããããããã¯NWOãæ¹ç§°ãããã®ã«ã»ããªããªãã
以äžã®åç»ã§ã¯ã調æ»ãžã£ãŒããªã¹ãã§ããããªãŒã»ãŽã©ãã¯ã¹ããç æ°ã®çºçãæ€ç«ãå€åºçŠæ¢ä»€ãæ¯é éçŽã®ããŒã«ãããã«äžå¯æ¬ ãªéå ·ã§ããããšããããŠãããã®éå ·ãæ¬¡ã®æ¯é ã®æ®µéãè¿ããããã«ã©ã®ããã«äœ¿ãããäºå®ã§ãã£ãããèªã£ãŠããŸãã
2014幎ã«è¡ããããã®ã€ã³ã¿ãã¥ãŒã¯ãå šäœäž»çŸ©çæ¯é ã«äžå¯æ¬ ãªããã3ã€ã®éå ·ã3幎åããç§ãã¡ã®çŸå®ã®äžéšãšãªã£ãŠãã仿¥ãå°ãªãããäºèšçã«èãããã®ã§ãã
ãã®äžã§Voxã¯ãããã¯ãã§ã©ãŒè²¡å£ã«ããææžããã¯ãããžãŒãšåœééçºã®æªæ¥ãžã®ã·ããªãªãã«ãèšåããŠãããããã§ã¯æ¶ç©ºã®ãã³ãããã¯ã«å¯Ÿããäžçã®å¯Ÿå¿ã詳述ãããããã¯ã¹ããããã·ããªãªãæç€ºããŠããŸãã
æçµçãªã²ãŒã å 容ã¯ãã§ã«èªãããŠãã
ãŠã€ã«ã¹ã®åç§°ãç±æ¥ã¯ç°ãªããããæè¡ãšåœééçºã®æªæ¥ã·ããªãªãã§ç€ºãããã·ããªãªã¯ãCOVID-19ã®æä»£ã«çµéšããããšãç¹ã«çµæžãžã®èŽåœçãªåœ±é¿ã«é ·äŒŒããŠããã
ã·ããªãªã§ã¯ãåœéçãªç§»åã寞æãããç£æ¥ã芳å ãã°ããŒãã«ãªãµãã©ã€ãã§ãŒã³ã衰匱ããŠããããšãäºæž¬ãããŠããããå°å ã§ãããã€ãã¯è³ãããªåºããªãã£ã¹ãã«ãäœã«æã空ãå®¶ãšãªããåŸæ¥å¡ã顧客ãããªããªã£ãããšããã
ããã¯ãã§ã©ãŒç€Ÿã®èª¬æã§ã¯ãäžåœã¯åœæ°çä¿éºå¶åºŠãè¿ éã«å°å ¥ãããŠã€ã«ã¹ã®èå»¶ãæå¶ããããšã«æåãããšè©äŸ¡ãããŠãããããã§éèŠãªã®ã¯ãå¥åº·ãªäººãéé¢ãããåœæ°çæ€ç«ãããããŸã§ææç察çã«äœ¿ãããããšã¯äžåºŠããªããšããããšã§ããã
ãã®çç±ã¯ããããããŸããããªãããã§ããã
ããã¯ãã§ã©ãŒã®ã·ããªãªã§ã¯ãæå°è ããæš©åšãèªç€ºãããåœæ°ã«å³ããå¶éã課ããä»ã®å€ãã®åœã -ããã§ã€ã¹ãã¹ã¯ã®ççšçŸ©åãããé§ ãã¹ãŒããŒããŒã±ãããªã©ã®å ±åã¹ããŒã¹ã®å ¥ãå£ã§ã®äœæž©ãã§ãã¯ãŸã§ã-ãããŸããã£ããšãããŠããã
Voxãã建ç©ã«å ¥ãåã«äœæž©ããã§ãã¯ããããã«åã«äžŠã°ãªããã°ãªããªãããããªããšãèµ·ããåŸããšæ¬åœã«ä¿¡ããŠããã®ãããšå°ãããšãã®ã€ã³ã¿ãã¥ã¢ãŒã®äžä¿¡æãèããŠã¿ãŠãã ããã
ãŸããç§ãã¡ã®èª°ããä»ãããããªããã°ãªããªãã®ã§ããããå¯èœã§ããããšã¯åãã£ãŠããŸãã
ãããŠããããããå¯èœãªãããªãããã¯ã¹ãããã»ãã©ã³ã®ä»ã®éšåã¯å¯èœã§ã¯ãªãã®ã§ãããããããã³ãããã¯ãå»ã£ãåŸããåžæ°ãšãã®æŽ»åã«å¯Ÿããæš©åšäž»çŸ©çãªç®¡çãšç£èŠã¯è¡°ãããããã匷åãããã®ã§ãã
éŠ¬é¹¿ã¯æ»ãªãªãããªãããªã
ã°ããŒããªã¹ãã®ãšãªãŒããéžæã§éžã°ããã®ã§ã¯ãªããã£ãŒãã»ã¹ããŒãããæ¯é æš©ãæ¡ãããã«ã©ããŸã§ãããããã¯ãä¿¡ããããã«ã¯ãããŸããã
äžçã®è³æºãå¯ã人ã ãæ¯é ããããã«ããã€ãªãããå©çšãããšãããã®ã§ãã
ç§ãã¡ã«å¿ èŠãªã®ã¯ããããä¿¡ããããšããããŠåœŒãã«æå¿ãæŒãä»ããåãäžããŠããã®ã¯ãç§ãã¡ã®ææå¿ã ãã ãšããããšãçè§£ããããšã§ããç§ãã¡ãææãéžæããæ¿åºãç§ãã¡ãå®å šã«ä¿ã€ããšãèŠæ±ããéãã圌ããåã€å¯èœæ§ã¯ååã«ããã
é¡ããã°ã倧倿°ã®äººã ãä»ãŸã§ã«ãã®æèšãåŠã³ãåãæå£ã«2床åŒã£ãããããšããªãããã«ããããã®ã ã
ä»å¹Žã®å¬ãåãæå£ã䜿ãã®ã ãããïŒ
ãã®éãã ã
ãã§ã«ãçŸåŸ³ãžã®åŒã³ãããå§ãŸã£ãŠããããã¹ã¯ççšãã¯ã¯ãã³æ¥çš®ã¯ä»»æã ãããä»äººãå®ãããã«ãæšå¥šãããšèšã£ãŠããã®ã ã
2020幎ã«å§ãŸã£ãããšã ãããã®çµæ«ã¯ã©ããªã£ããã
ãŸãåãããšãç¹°ãè¿ãããã®ãïŒããã§ãªããªããæåãããããŒããšèšãã°ããã®ã§ãã
ãã¹ã¯ããã¡ã瀟äŒçè·é¢ã眮ãã®ããã¡ãäŒæ¥ããã£ã³ã»ã«ããã®ããã¡ãããã¯ããŠã³ãããªããã€ã³ãã«ãšã³ã¶ã¯ã¯ãã³ãCOVID-19ã®æ³šå°ãããŒãšèšããããã ãææãç œã圌ãã«ãããŒããšèšããèªåã®äººçãçããã°ããã®ã§ãã
ææã¯ããªããã³ã³ãããŒã«ããããã«äœ¿ãããããŒã«ã§ãããããã¯ããªãããããåãå ¥ããå Žåã«ã®ã¿æ©èœããŸãã
ææãæšãŠãèªåã®å¥åº·ãã³ã³ãããŒã«ããã
ã€ã³ãã«ãšã³ã¶ãRSVãCOVID-19ã¯ãç¹å®ã®ãã€ãªã¹ã¯è ã«ãšã£ãŠåé¡ã§ããå±éºã§ããããããã«é¢é£ããå šäœçãªãªã¹ã¯ã¯ãã»ãšãã©ã®äººã«ãšã£ãŠç¡èŠã§ãããã®ã§ãã
ããªãã®äººçãæ¯ãè¿ã£ãŠã¿ãŠãã ãããäœåºŠé¢šéªãã€ã³ãã«ãšã³ã¶ã«ããã£ãããšããããŸããïŒããªãã¯ãŸã ããã«ããŸããïŒé¢šéªãã€ã³ãã«ãšã³ã¶ãåå ã§æ»äº¡ãã人ãäœäººç¥ã£ãŠããŸããïŒ
ãã®æç¹ã§ã倧倿°ã®äººãCOVID-19ã«ããã£ãããšãããããã®éèŽæ»æ§ã蚌æããããã«ããã«ããã®ã§ãã
ããããæ®å¿µãªãããCOVID-19ãäœåºŠãæ¥çš®ããŠãã人ã¯ããã€ãªã¹ã¯ã«ããŽãªãŒã«å ¥ããããã£ãŠéçåããå¯èœæ§ããããããããäºé²æ¥çš®ãåããŠããªãæ¹ã«ãšã£ãŠã¯ããã®ææ°åã¯æ¥µããŠäœããªã¹ã¯ã§ãã
å ç«åãé«ããŠããããšã¯ãããããææçãã身ãå®ãããã®æåã®æ¹æ³ã§ããããã®ããã®å¹æçãªæ¹æ³ã¯ã以äžã®ããã«ãããããããŸãã
詳ããã¯ããªã³ã¯å ãã芧ãã ããã
ãã¿ãã³Dã®ã¬ãã«ãæé©åãã - ãã¿ãã³Dã®ã¬ãã«ãé«ããšãCOVID-19ã®éçåãããã³æ»äº¡ã®ãªã¹ã¯ãäœäžããããšã瀺ãããŠããŸãããŸãããã¿ãã³Dã®è£çµŠã¯ãèªç¶å ç«ãé«ããã®ã§ã颚éªãã€ã³ãã«ãšã³ã¶ã®ãªã¹ã¯ãæžããããšã瀺ãããŠããŸãã
æéå¶éã®ããé£äºãšæç¶çãªæé£ - ã©ã¡ããCOVID-19ææã®éçåæå¶ã«ã€ãªããããšãåãã£ãŠããŸãã
ãã¿ãã³Cãã±ã«ã»ãã³ãäºéãN-ã¢ã»ãã«ã·ã¹ãã€ã³ïŒNACïŒãªã©ã®å ç«åãé«ããæ é€è£å©é£å - äºéã¯åŒ·åãªåºåæãŠã€ã«ã¹å€ã§ãã±ã«ã»ãã³ã¯ãããå¿ èŠãªçްèå ãžéã¶ã®ãå©ããŸãããŸãããã¿ãã³Cã¯å€ãã®ææçã®æ²»çè¬ãšããŠå©çšãããå ç«æ©èœãé«ããã®ã«åœ¹ç«ã£ãŠããŸãã
äžæ¹ãNACã¯éå åã°ã«ã¿ããªã³ã®åé§äœã§ãããç¹ã«COVID-19ã«ãããŠéèŠãªåœ¹å²ãæãããšæãããŸãã
NACã®å©ç¹ã«ã¯ãççæ§ãµã€ãã«ã€ã³ã®çºçŸãæå¶ããT现èåå¿ãæ¹åããèºã§ã®é žçŽ äº€æèœåãæãªãè³åäžããã³/ãŸãã¯è¡æ ãããããå¯èœæ§ã®ããååºäº¢é²ãæå¶ããããšãå«ãŸããŸãã
åæïŒMercola.
ãã®èšäºã§ç€ºãããèŠè§£ããã³æèŠã¯èè ã®ãã®ã§ãããå¿ ãããChildren's Health Defenseã®èŠè§£ãåæ ãããã®ã§ã¯ãããŸããã